These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9796750)

  • 1. Pharmacoeconomic considerations in treatment options for acute seizures.
    Graves N
    J Child Neurol; 1998 Oct; 13 Suppl 1():S27-9; discussion S30-2. PubMed ID: 9796750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosphenytoin. Pharmacoeconomic implications of therapy.
    Holliday SM; Benfield P; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):685-90. PubMed ID: 10346419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments.
    Marchetti A; Magar R; Fischer J; Sloan E; Fischer P
    Clin Ther; 1996; 18(5):953-66. PubMed ID: 8930434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department.
    Rudis MI; Touchette DR; Swadron SP; Chiu AP; Orlinsky M
    Ann Emerg Med; 2004 Mar; 43(3):386-97. PubMed ID: 14985668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin and fosphenytoin: a model of cost and clinical outcomes.
    Armstrong EP; Sauer KA; Downey MJ
    Pharmacotherapy; 1999 Jul; 19(7):844-53. PubMed ID: 10417033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.
    Beghi E; Capovilla G; Franzoni E; Minicucci F; Romeo A; Verrotti A; Vigevano F; Perucca E
    Acta Neurol Scand; 2018 Jan; 137(1):24-28. PubMed ID: 28875555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosphenytoin farewell?
    Horowitz BZ
    Ann Emerg Med; 2004 Mar; 43(3):398-400. PubMed ID: 14985669
    [No Abstract]   [Full Text] [Related]  

  • 9. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of fosphenytoin: options for the management of seizures.
    Ramsay RE; DeToledo J
    Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate fosphenytoin use in the ED.
    Johnson J; Wrenn K
    Am J Emerg Med; 2001 Jul; 19(4):293-4. PubMed ID: 11447516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional modalities for treating acute seizures in children: overview.
    Bebin EM
    J Child Neurol; 1998 Oct; 13 Suppl 1():S23-6; discussion S30-2. PubMed ID: 9796749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosphenytoin: a novel phenytoin prodrug.
    Boucher BA
    Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of convulsive status epilepticus in infants and children].
    Hubert P; Parain D; Vallée L
    Rev Neurol (Paris); 2009 Apr; 165(4):390-7. PubMed ID: 19264335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug therapy for acute seizure management.
    Morton LD; Rizkallah E; Pellock JM
    Semin Pediatr Neurol; 1997 Mar; 4(1):51-63. PubMed ID: 9097367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis.
    Nakazawa M; Toda S; Abe S; Ikeno M; Igarashi A; Nakahara E; Yamashita S; Niijima S; Shimizu T; Okumura A
    Brain Dev; 2015 Oct; 37(9):864-7. PubMed ID: 25708686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of fosphenytoin.
    Fierro L; Hudak J
    Ann Emerg Med; 1998 Jan; 31(1):137-8; author reply 138-9. PubMed ID: 9437361
    [No Abstract]   [Full Text] [Related]  

  • 19. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
    Popławska M; Borowicz KK; Czuczwar SJ
    Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.